March 17 (Reuters) - Pfizer said on Tuesday its experimental combination reduced the risk of disease progression or death by ...

Pfizer’s CDK4 inhibitor, atirmociclib, is already being investigated in a Phase III trial as a first-line therapy.

China has approved a new obesity treatment from Pfizer Inc., heightening competition in a market poised to become even more ...

Pfizer is betting on a new breast cancer drug combo that, in a key mid-stage trial, cut the risk of the disease worsening or ...

Pfizer has reached a turning point.

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...

Add Yahoo as a preferred source to see more of our stories on Google. WASHINGTON ‒ President Donald Trump announced a deal with Pfizer for the drugmaker to voluntarily sell medications through ...

President Donald Trump on Tuesday announced measures aimed at lowering the cost of prescription drugs in the United States, including an agreement with pharmaceutical giant Pfizer and the creation of ...

All 16 of the drug manufacturers that signed deals with Trump have issued price hikes this year, according to reports.